Andrew Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrew Zelenetz, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:45 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04416451 · A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone LymphomaMemorial Sloan Kettering Cancer Center · active not recruiting · Marginal Zone Lymphoma · principal investigator
- Ph2NCT03824483 · Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)Memorial Sloan Kettering Cancer Center · active not recruiting · Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) · principal investigator
- Ph1/Ph2NCT02282358 · Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular LymphomaMemorial Sloan Kettering Cancer Center · terminated · Lymphoma, Relapsed and Refractory, Diffuse Large B-Cell Lymphoma and Follicular Lymphoma · principal investigator
- Ph1/Ph2NCT01484093 · Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell LymphomaMemorial Sloan Kettering Cancer Center · completed · Mantle Cell Lymphoma · principal investigator
- Ph2NCT00712582 · Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell LymphomaMemorial Sloan Kettering Cancer Center · completed · Non-Hodgkin's Lymphoma · principal investigator
- Ph2NCT00005964 · Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaAlliance for Clinical Trials in Oncology · completed · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer and Leukemia Group BU10CA031946 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Monica M Bertagnolli · fiscal years 1985 to 2013Named on NCT00005964
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.